Vident Investment Advisory, LLC Merck & Co., Inc. Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $8.28 Million - $9.03 Million	-76,249 Reduced 33.01%	154,716 $17.9 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $633,595 - $706,963	-6,155 Reduced 2.6%	230,965 $24.6 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $15.8 Million - $20.3 Million	181,059 Added 322.97%	237,120 $26.3 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $758,403 - $851,981	8,972 Added 19.05%	56,061 $3.5 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $2.72 Million - $3.08 Million	-32,534 Reduced 40.86%	47,089 $4.29 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $1.63 Million - $1.83 Million	-22,195 Reduced 21.8%	79,623 $6.53 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $1.01 Million - $1.26 Million	13,958 Added 15.89%	101,818 $7.8 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $1.07 Million - $1.18 Million	14,994 Added 20.58%	87,860 $6.6 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $1.3 Million - $1.44 Million	18,532 Added 34.11%	72,866 $5.67 Million
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $1.07 Million - $1.26 Million	-15,517 Reduced 22.21%	54,334 $4.19 Million
Q4 2020 Feb 08, 2021	BUY	$71.77 - $79.65 $462,988 - $513,822	6,451 Added 10.18%	69,851 $5.71 Million
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $1.38 Million - $1.56 Million	18,795 Added 42.14%	63,400 $5.26 Million
Q2 2020 Jul 28, 2020	SELL	$70.42 - $80.13 $6.96 Million - $7.92 Million	-98,883 Reduced 68.91%	44,605 $3.45 Million
Q2 2020 Jul 17, 2020	BUY	$70.42 - $80.13 $7.33 Million - $8.34 Million	104,040 Added 263.74%	143,488 $11.1 Million
Q1 2020 May 12, 2020	SELL	$63.36 - $87.82 $1.4 Million - $1.95 Million	-22,153 Reduced 35.96%	39,448 $3.04 Million
Q4 2019 Feb 11, 2020	BUY	$77.58 - $87.54 $2.17 Million - $2.45 Million	27,999 Added 83.33%	61,601 $5.6 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $589,620 - $642,707	-7,750 Reduced 18.74%	33,602 $2.83 Million
Q2 2019 Aug 12, 2019	SELL	$69.84 - $81.59 $2.5 Million - $2.93 Million	-35,865 Reduced 46.45%	41,352 $3.47 Million
Q1 2019 May 08, 2019	BUY	$69.58 - $79.36 $2.17 Million - $2.47 Million	31,163 Added 67.67%	77,217 $6.42 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $652,595 - $757,327	-10,003 Reduced 17.84%	46,054 $3.52 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $242,701 - $285,402	-4,207 Reduced 6.98%	56,057 $3.98 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $483,850 - $568,474	9,519 Added 18.76%	60,264 $3.66 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $403,552 - $469,042	7,919 Added 18.49%	50,745 $2.98 Million
Q4 2017 Feb 15, 2018	BUY	$51.62 - $61.64 $273,947 - $327,123	5,307 Added 14.14%	42,826 $2.41 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $2.2 Million - $2.37 Million	37,519	37,519 $2.4 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$25.8 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$21.4 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$12.3 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.82 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$6.1 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account